Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: January 24, 2020

DrugPatentWatch Database Preview

Zydus Pharms Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for ZYDUS PHARMS, and what generic and branded alternatives to ZYDUS PHARMS drugs are available?

ZYDUS PHARMS has two hundred and two approved drugs.

There are nineteen tentative approvals on ZYDUS PHARMS drugs.

Summary for Zydus Pharms
US Patents:0

Drugs and US Patents for Zydus Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms TOPIRAMATE topiramate CAPSULE, EXTENDED RELEASE;ORAL 207382-001 Nov 24, 2017 AB RX No No   Start Trial   Start Trial
Zydus Pharms Usa Inc LOSARTAN POTASSIUM losartan potassium TABLET;ORAL 078243-001 Oct 6, 2010 AB RX No No   Start Trial   Start Trial
Zydus Pharms LEVOFLOXACIN levofloxacin INJECTABLE;INJECTION 205968-002 Jun 1, 2017 DISCN No No   Start Trial   Start Trial
Zydus Pharms CANDESARTAN CILEXETIL candesartan cilexetil TABLET;ORAL 091390-001 Aug 23, 2017 AB RX No No   Start Trial   Start Trial
Zydus Pharms Usa Inc RAMIPRIL ramipril TABLET;ORAL 090697-001 Sep 24, 2009 DISCN No No   Start Trial   Start Trial
Zydus Pharms FESOTERODINE FUMARATE fesoterodine fumarate TABLET, EXTENDED RELEASE;ORAL 204946-002 Oct 3, 2017 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for ZYDUS PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.